reduc estim reflect us hospit
lockdown risk rais
reiter outperform
chang model made chang model reflect revis
analysi framework incorpor near-term pressur us elect surgeri
addit intermediate-term risk relat bax major busi
reduc ep estim
respect also reduc sale estim
bil bil respect reflect organ growth
respect previou estim despit sharp drop
elect surgeri back half march expect declin april expect
 surgeri begin open back may eas restrict june
juli remain consider uncertainti rate return surgeri
 potenti impact flu season hospit protocol
believ analysi framework captur much potenti rang effect
comfort point base case scenario reflect
new estim middl rang rais target price
reiter outperform rate
new estim reflect base case assumpt across rang risk
factor analysi contempl potenti impact defer procedur
procedur less deferr capit equip flu care diagnost
busi line also take account geograph exposur bax major
busi china apac ex-china ou ex-apac us final consid
potenti rang durat may see pressur slowdown variou
busi degre hospit system may oper partial
capac differ time next month expect measur pace
surgeri begin certain center certain region mid-may
improv june juli also revis framework assum
greater portion base case lost defer procedur reschedul
ultim perform next sever quarter addit detail analysi
framework behind estim chang pleas see correspond sector
updat estim revis make reduct estim
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
inc global manufactur provid
diversifi healthcar suppli equip area renal
one-year valuat scenario base
ev/ebitda ebitda bil
one-year valuat grey scenario base
ev/ebitda grey ebitda bil
 close
chang model
figur chang model
figur estimate chang sale estim
estim figur interact model initi revis refer
estim revis
valuat target price base multipl
revis ntm ebitda previous ntm ebitda bil one year
forward risk product delay failur reach lt goal litig regulatory/qu issu
greater expect impact
compani mention price
matt miksic certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
